220 related articles for article (PubMed ID: 27214383)
1. The randomized clinical trial of coenzyme Q10 for the prevention of periprocedural myocardial injury following elective percutaneous coronary intervention.
Aslanabadi N; Safaie N; Asgharzadeh Y; Houshmand F; Ghaffari S; Garjani A; Dousti S; Hamishehkar H; Entezari-Maleki T
Cardiovasc Ther; 2016 Aug; 34(4):254-60. PubMed ID: 27214383
[TBL] [Abstract][Full Text] [Related]
2. Effect of Vitamin D in the Prevention of Myocardial Injury Following Elective Percutaneous Coronary Intervention: A Pilot Randomized Clinical Trial.
Aslanabadi N; Jafaripor I; Sadeghi S; Hamishehkar H; Ghaffari S; Toluey M; Azizi H; Entezari-Maleki T
J Clin Pharmacol; 2018 Feb; 58(2):144-151. PubMed ID: 28841229
[TBL] [Abstract][Full Text] [Related]
3. A pilot randomized trial of pentoxifylline for the reduction of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
Aslanabadi N; Shirzadi HR; Asghari-Soufi H; Dousti S; Ghaffari S; Sohrabi B; Mashayekhi SO; Hamishehkar H; Entezari-Maleki T
Eur J Clin Pharmacol; 2015 Feb; 71(2):143-9. PubMed ID: 25475357
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of lipid microspheres 1 on myocardial injury following elective percutaneous coronary intervention in patients with angina pectoris: a pilot study.
Chu-fan L; Xing W; Xun H; Gui-fu W; Cheng-heng H; Zhi-min D
J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):790-4. PubMed ID: 21934521
[TBL] [Abstract][Full Text] [Related]
5. The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention.
Wang ZJ; Hu WK; Liu YY; Shi DM; Cheng WJ; Guo YH; Yang Q; Zhao YX; Zhou YJ
Can J Cardiol; 2014 Jan; 30(1):96-101. PubMed ID: 24365194
[TBL] [Abstract][Full Text] [Related]
6. A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention.
Pelliccia F; Pasceri V; Marazzi G; Rosano G; Greco C; Gaudio C
Am Heart J; 2012 Jun; 163(6):1019-23. PubMed ID: 22709755
[TBL] [Abstract][Full Text] [Related]
7. Naproxen treatment prevents periprocedural inflammatory response but not myocardial injury after percutaneous coronary intervention.
Ozdol C; Gulec S; Rahimov U; Atmaca Y; Turhan S; Erol C
Thromb Res; 2007; 119(4):453-9. PubMed ID: 17157900
[TBL] [Abstract][Full Text] [Related]
8. Effect of intracoronary nicardipine on cardiac enzymes after elective percutaneous coronary intervention.
Arora S; Alfayoumi F; Khawaja AT; Dua A; Srinivasan V; Gradman AH
Clin Cardiol; 2009 Jun; 32(6):315-20. PubMed ID: 19569065
[TBL] [Abstract][Full Text] [Related]
9. With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention.
Lim CC; van Gaal WJ; Testa L; Cuculi F; Arnold JR; Karamitsos T; Francis JM; Petersen SE; Digby JE; Westaby S; Antoniades C; Kharbanda RK; Burrell LM; Neubauer S; Banning AP
J Am Coll Cardiol; 2011 Feb; 57(6):653-61. PubMed ID: 21292125
[TBL] [Abstract][Full Text] [Related]
10. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
[TBL] [Abstract][Full Text] [Related]
11. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
Niccoli G; Sgueglia GA; Latib A; Crea F; Colombo A;
Catheter Cardiovasc Interv; 2014 Jan; 83(1):E37-44. PubMed ID: 23813627
[TBL] [Abstract][Full Text] [Related]
12. Use of troponin to diagnose periprocedural myocardial infarction: effect on composite endpoints in the British Bifurcation Coronary Study (BBC ONE).
Cockburn J; Behan M; de Belder A; Clayton T; Stables R; Oldroyd K; Curzen N; Hildick-Smith D
Heart; 2012 Oct; 98(19):1431-5. PubMed ID: 22851684
[TBL] [Abstract][Full Text] [Related]
13. Protection from procedural myocardial injury by omega-3 polyunsaturated fatty acids (PUFAs): is related with lower levels of creatine kinase-MB (CK-MB) and troponin I?
Foroughinia F; Salamzadeh J; Namazi MH
Cardiovasc Ther; 2013 Oct; 31(5):268-73. PubMed ID: 23134549
[TBL] [Abstract][Full Text] [Related]
14. Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention.
Mehta V; Sukhija R; Mehra P; Goyal A; Yusuf J; Mahajan B; Gupta VK; Tyagi S; Palaniswamy C; Aronow WS
Indian Heart J; 2016; 68(1):57-62. PubMed ID: 26896268
[TBL] [Abstract][Full Text] [Related]
15. The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention.
Fujii K; Kawasaki D; Oka K; Akahori H; Iwasaku T; Fukunaga M; Eguchi A; Sawada H; Masutani M; Lee-Kawabata M; Tsujino T; Ohyanagi M; Masuyama T
JACC Cardiovasc Interv; 2011 May; 4(5):513-20. PubMed ID: 21596324
[TBL] [Abstract][Full Text] [Related]
16. Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry.
Zhang Q; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Kirtane AJ; Zhang RY
Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():616-23. PubMed ID: 26864270
[TBL] [Abstract][Full Text] [Related]
17. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.
Gibson CM; Karmpaliotis D; Kosmidou I; Murphy SA; Kirtane AJ; Budiu D; Ray KK; Herrmann HC; Lakkis N; Kovach R; French W; Blankenship J; Lui HH; Palabrica T; Jennings LK; Cohen DJ; Morrow DA;
Am J Cardiol; 2006 May; 97(10):1473-7. PubMed ID: 16679086
[TBL] [Abstract][Full Text] [Related]
18. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
[TBL] [Abstract][Full Text] [Related]
19. Periprocedural myocardial injury in chronic total occlusion percutaneous interventions: a systematic cardiac biomarker evaluation study.
Lo N; Michael TT; Moin D; Patel VG; Alomar M; Papayannis A; Cipher D; Abdullah SM; Banerjee S; Brilakis ES
JACC Cardiovasc Interv; 2014 Jan; 7(1):47-54. PubMed ID: 24332422
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]